Cystic Fibrosis News headline with a megaphone icon. Summary: CF results from CFTR gene mutations leading to mucus issues. 4D-710 aims to deliver a healthy CFTR gene to improve lung function using a virus vector.
Learn about new progress: https://bit.ly/3W2Prij
The Cystic Fibrosis Foundation is investing up to $11 million more in 4D Molecular Therapeutics to advance its inhaled gene therapy, 4D-710, now in Phase 2 trials.
#CysticFibrosisNews #CysticFibrosis #GeneTherapy #4DMT #ClinicalTrials #Bionews
0
0
0
0
